- Home
- UAN vs YDES Comparison
UAN vs YDES Comparison
Compare UAN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UAN | YDES |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 894.2M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | UAN | YDES |
|---|---|---|
| Price | $99.57 | $8.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.0K | 23.4K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 10.51% | N/A |
| EPS Growth | ★ 61.98 | N/A |
| EPS | ★ 9.33 | N/A |
| Revenue | ★ $606,038,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.74 | ★ N/A |
| Revenue Growth | ★ 15.36 | N/A |
| 52 Week Low | $63.45 | $7.90 |
| 52 Week High | $119.90 | $25.00 |
Technical Indicators
Market Signals| Indicator | UAN | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 40.10 |
| Support Level | $99.50 | $8.19 |
| Resistance Level | $112.40 | $13.19 |
| Average True Range (ATR) | 4.52 | 0.77 |
| MACD | -0.98 | -0.12 |
| Stochastic Oscillator | 27.44 | 26.84 |
Price Performance
Historical ComparisonAbout UAN CVR Partners LP
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.